DMAB
Live / Allowed — Third extension granted (statement of use) (as of 03 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Oct 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97632191
- Mark type
- Word mark
- Filed
- 14 Oct 2022
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations comprising nucleic acid encoded monoclonal antibody proteins produced in vivo for the treatment of cancers, genetic disorders, infectious diseases, and chronic diseases
Owner
- Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, US
- Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, US
Prosecution history
- 04 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2026 — SOU EXTENSION 3 GRANTED
- 03 Jun 2026 — SOU EXTENSION 3 FILED
- 03 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Dec 2025 — SOU EXTENSION 2 GRANTED
- 03 Dec 2025 — SOU EXTENSION 2 FILED
- 03 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2025 — SOU EXTENSION 1 GRANTED
- 03 Jun 2025 — SOU EXTENSION 1 FILED
- 03 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2024 — PUBLISHED FOR OPPOSITION